| Researchers’ views on, and experiences with, the requirement to obtain informed consent in research involving human participants: A qualitative study A Xu, MT Baysari, SL Stocker, LJ Leow, RO Day, JE Carland BMC medical ethics 21, 1-11, 2020 | 308 | 2020 |
| Clinical pharmacokinetics in kidney disease: fundamental principles TN Lea-Henry, JE Carland, SL Stocker, J Sevastos, DM Roberts Clinical journal of the American society of nephrology 13 (7), 1085-1095, 2018 | 261 | 2018 |
| Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting A Broeker, M Nardecchia, KP Klinker, H Derendorf, RO Day, DJ Marriott, ... Clinical Microbiology and Infection 25 (10), 1286. e1-1286. e7, 2019 | 142 | 2019 |
| Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and α4β2 nicotinic acetylcholine receptors TG Hales, JI Dunlop, TZ Deeb, JE Carland, SP Kelley, JJ Lambert, ... Journal of Biological Chemistry 281 (12), 8062-8071, 2006 | 114 | 2006 |
| Clinical pharmacokinetics in kidney disease: application to rational design of dosing regimens DM Roberts, J Sevastos, JE Carland, SL Stocker, TN Lea-Henry Clinical Journal of the American Society of Nephrology 13 (8), 1254-1263, 2018 | 99 | 2018 |
| Glycine transport inhibitors for the treatment of pain RJ Vandenberg, RM Ryan, JE Carland, WL Imlach, MJ Christie Trends in pharmacological sciences 35 (8), 423-430, 2014 | 93 | 2014 |
| Methyllycaconitine analogues have mixed antagonist effects at nicotinic acetylcholine receptors D Barker, DHS Lin, JE Carland, CPY Chu, M Chebib, MA Brimble, ... Bioorganic & medicinal chemistry 13 (14), 4565-4575, 2005 | 73 | 2005 |
| A model averaging/selection approach improves the predictive performance of model‐informed precision dosing: vancomycin as a case study DW Uster, SL Stocker, JE Carland, J Brett, DJE Marriott, RO Day, ... Clinical Pharmacology & Therapeutics 109 (1), 175-183, 2021 | 70 | 2021 |
| Characterization of the effects of charged residues in the intracellular loop on ion permeation in α1 glycine receptor channels JE Carland, MA Cooper, S Sugiharto, HJ Jeong, TM Lewis, PH Barry, ... Journal of Biological Chemistry 284 (4), 2023-2030, 2009 | 69 | 2009 |
| Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor MR Livesey, MA Cooper, TZ Deeb, JE Carland, J Kozuska, TG Hales, ... Journal of Biological Chemistry 283 (28), 19301-19313, 2008 | 62 | 2008 |
| Population pharmacokinetic models of tacrolimus in adult transplant recipients: a systematic review R Kirubakaran, SL Stocker, S Hennig, RO Day, JE Carland Clinical Pharmacokinetics 59, 1357-1392, 2020 | 57 | 2020 |
| Novel structural determinants of single channel conductance and ion selectivity in 5‐hydroxytryptamine type 3 and nicotinic acetylcholine receptors JA Peters, MA Cooper, JE Carland, MR Livesey, TG Hales, JJ Lambert The Journal of physiology 588 (4), 587-596, 2010 | 56 | 2010 |
| Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients CB Cunio, DW Uster, JE Carland, H Buscher, Z Liu, J Brett, M Stefani, ... Clinical Microbiology and Infection 27 (5), 783. e7-783. e14, 2021 | 49 | 2021 |
| Patients’ use of mobile health applications: what general practitioners think AD Nguyen, LJ Frensham, MT Baysari, JE Carland, RO Day Family practice 36 (2), 214-218, 2019 | 46 | 2019 |
| Synthesis and characterization of novel acyl-glycine inhibitors of GlyT2 SN Mostyn, JE Carland, S Shimmon, RM Ryan, T Rawling, ... ACS chemical neuroscience 8 (9), 1949-1959, 2017 | 41 | 2017 |
| Oleoyl‐l‐carnitine inhibits glycine transport by GlyT2 JE Carland, RE Mansfield, RM Ryan, RJ Vandenberg British journal of pharmacology 168 (4), 891-902, 2013 | 34 | 2013 |
| Identification of a 3rd Na+ Binding Site of the Glycine Transporter, GlyT2 N Subramanian, AJ Scopelitti, JE Carland, RM Ryan, ML O’Mara, ... PLoS One 11 (6), e0157583, 2016 | 31 | 2016 |
| Dynamic modification of a mutant cytoplasmic cysteine residue modulates the conductance of the human 5-HT3A receptor TZ Deeb, JE Carland, MA Cooper, MR Livesey, JJ Lambert, JA Peters, ... Journal of Biological Chemistry 282 (9), 6172-6182, 2007 | 31 | 2007 |
| Charged residues at the 2′ position of human GABAC ρ1 receptors invert ion selectivity and influence open state probability JE Carland, AJ Moorhouse, PH Barry, GAR Johnston, M Chebib Journal of Biological Chemistry 279 (52), 54153-54160, 2004 | 31 | 2004 |
| Allopurinol: insights from studies of dose–response relationships RO Day, DRW Kannangara, SL Stocker, JE Carland, KM Williams, ... Expert opinion on drug metabolism & toxicology 13 (4), 449-462, 2017 | 28 | 2017 |
Richard O. DayProfessor of Clinical Pharmacology, University of New South Wales and St Vincent's Hospital, SydneyПідтверджена електронна адреса в unsw.edu.au
